Multicystic dysplastic kidney medical therapy

Multicystic dysplastic kidney Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multicystic dysplastic kidney from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Voiding Cystourethrography (VCUG)
Dimercaptosuccinic Acid (DMSA) Renal Scanning
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Multicystic dysplastic kidney medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multicystic dysplastic kidney medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multicystic dysplastic kidney medical therapy
CDC on Multicystic dysplastic kidney medical therapy
Multicystic dysplastic kidney medical therapy in the news
Blogs on Multicystic dysplastic kidney medical therapy
Directions to Hospitals Treating Multicystic dysplastic kidney
Risk calculators and risk factors for Multicystic dysplastic kidney medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

MCDK is not treatable. However, the patient is observed periodically for the first few years during which ultrasounds are generally taken to ensure the healthy kidney is functioning properly and that the unhealthy kidney is not causing adverse effects.